Sorted:

Introducing Patient Tags in Chemotherapy Manager

Introducing Patient Tags in Chemotherapy Manager

Patient tags have been introduced in the Chemotherapy Manager to ensure that all patient tags relevant to a patient profile are displayed in the chemotherapy manager. This enhancement helps in compiling the information when the user looks up a patient, an order or an admin by leveraging the relevant tags.

Following are the enhanced areas in this feature:

  1. Patient banner UI
  2. Patient Profile
  3. Search Module
  4. Flowsheet
Incorporating the Latest Versions of American Joint Committee on Cancer in the Chemo Manager

Incorporating the Latest Versions of American Joint Committee on Cancer in the Chemo Manager

With this enhancement, the system supports the latest versions of the American Joint Committee on Cancer (AJCC) cancer staging (versions 8 and 9). This ensures that through the AJCC cancer staging, the healthcare professionals have the ability to document the clinical data related to a patient's cancer stage.

Enhancements in Adverse Event in Chemotherapy Manager

Enhancements in Adverse Event in Chemotherapy Manager

Enhancements have been made to the Adverse Events Module in the Chemotherapy Manager including Resolution Reason for Adverse Event, Serious Adverse Event and Relationship Section.

Introduction of JZ Modifier in the Billing Section of Practice Configuration

Introduction of JZ Modifier in the Billing Section of Practice Configuration

In line with new CMS guidelines effective July 1, 2023, healthcare practices need to use the JZ modifier when billing for drugs, specifically when no amount is discarded from a single-dose container. This requirement applies to all such claims that are submitted by the practices. Hence, to ensure that the billing process complies with this requirement, JZ modifier has been introduced to the Chemotherapy Manager.

Enhancements in Carbo Dosing Rules on Practice Configuration

Enhancements in Carbo Dosing Rules on Practice Configuration

With this enhancement, practices have the ability to set precise limits for Serum Creatinine values and Creatinine Clearance levels when determining AUC-based drug dosing. By customizing these limits, healthcare providers can ensure personalized and effective patient care.